Bay Area Lyme Foundation raised $900,000 at its LymeAid 2026 gala to support research for better Lyme disease diagnostics and treatments. The event featured the inaugural Neil L. Spector, MD, Legacy Award recognizing transformative research, awarded to Dr. Timothy Haystead. Additionally, $300,000 in Emerging Leader Grants were given to promising researchers studying Lyme and tick-borne diseases. The foundation continues to advance innovative projects, including advanced diagnostics and clinical trials, aiming to improve patient outcomes and develop targeted therapies.
A class action lawsuit has been filed against Zoetis Inc. and certain officers, alleging they made false statements about the growth and market share of key products in the Companion Animal segment. The complaint claims Zoetis failed to disclose weak...
Chevron CEO Mike Wirth highlighted at a recent conference that coal consumption is expected to remain stronger than previously forecasted, and supplying gas-fired power to data centers could become a significant growth area. The company also noted po...
DaSouChe Holdings Ltd. (DSC) has filed for a Nasdaq listing, backed by major underwriters including Deutsche Bank and ICBC. DSC reported revenues of RMB 909M in 2023, RMB 948M in 2024, and RMB 677M in 2025, with a narrowing net loss over the same per...
Alternative Ballistics Corporation, a public safety tech company specializing in less-lethal defense solutions, will present live at the Small Cap Growth Virtual Investor Conference on June 4, 2026. The company recently listed on the OTCQB market and...
More than 15 pharmaceutical companies are actively developing over 20 drugs for synovial sarcoma, a rare and aggressive cancer. Key players like Takara Bio, Immatics, and ModernaTX are testing promising therapies in various clinical trial phases, inc...
